Acute myeloid leukemia, abbreviated as AML, is a type of blood cancer, when myeloid white blood cells multiply in an abnormally fast rate, which interferes with production of normal blood cells. All blood in human body is produced in bone marrows, which are overloaded beyond their capacity when cancerous cells start to grow uncontrollably. AML is more likely to affect adults than children, and the incidence probability increases with age.
The symptoms of myeloid leukemia are not self descriptive, and may lead to wrong diagnosis without proper examination. Fatigue, shortness of breath, predisposition to bruising and bleeding are all common signs of a variety of conditions, so one must attend a physician if such problems persist for more than two weeks. Although the cause of this condition is never clear, and risk factors are now known to avoid them, myeloid leukemia tends to progress rapidly and can become fatal within months or even weeks, if left untreated.
Treatment of leukemia, much like other cancer-related conditions, will most likely require several courses of chemotherapy and/or radiation therapy. While being the most effective of cancer treatments known today, they are not very pleasant to the patient, and have a very high risk of producing harmful side effects. Some studies suggest that medical marijuana can help wearing off side effects associated with harsh therapies, and at the same time, increase appetite to make sure the body receives proper nutrition. Also, the THC component of marijuana has been tested as alternative destroyer of cancer cells. A number of clinical experiments show that cannabiniods indeed have cancer-fighting properties, and are able to successfully reduce tumor growth. Using medical marijuana as either side effect reliever in combination with chemotherapy, or as supportive medication, may potentially promote longer-term rate of life expectancy.